According to the Chapter Strategic Focus, All of the Following

Multiple Choice

According to the chapter Strategic Focus, all of the following are reasons why Pfizer concluded that the acquisition of Wyeth was in the best interest of stakeholders EXCEPT

A) Wyeth had been investing heavily in biotechnology and vaccines for about three decades.
B) Pfizer wanted to gain access to new products that might flow from Wyeth's biotechnology-oriented R&D investments.
C) Lipitor was a failure for Pfizer and Wyeth had the potential to contribute a top-selling drug.
D) Wyeth could contribute to Pfizer's sales revenue which was expected to decline when Lipitor came off patent.